Abstract

PostScription: Experts Everywhere

Author(s): Rahe Hank

Issue: Mar/Apr 2005 - Health and Wellness

Page(s): 167

Download in electronic PDF format for $75
  • PostScription: Experts Everywhere Page 1

Abstract

Recent articles by individuals associated with the Controlled Environmental Testing Association (CETA) offer recommendations for barrier isolators used in pharmacy compounding. These recommendations are based, however, on misinterpretations of US Food and Drug Administration (FDA) policy, confusing guidelines for manufacturing with guidelines for compounding. United States Pharmacopeia (USP) Chapter <797> is an enforceable standard for compounding sterile preparations, while FDA regulations govern drug manufacturing processes. Great care has been taken in the construction of USP Chapter <797> to separate the requirements of manufacturing from the pharmacist’s right to compound. Compounding under the definitions and requirements outlined in USP Chapter <797> provide a safe environment without adding the more stringent requirements of the manufacturing environment. Confusing the requirements, as in the CETA documents, not only creates confusion but also endangers the intended separation of manufacturing and compounding.

Related Keywords

  • barrier isolators
  • cleanroom
  • United States Pharmacopeia
  • USP Chapter <797>
  • US Food and Drug Administration
  • FDA
  • airflow
  • sterile preparation

Related Categories

  • LEGAL
  • STERILE PREPARATIONS
  • UNITED STATES PHARMACOPEIA CONVENTIONS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2020
Pg. 92
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 180
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2
Author(s): Allen Loyd V Jr
Sep/Oct 2018
Pg. 401-404
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Author(s): Martin Matt
Nov/Dec 2021
Pg. 491-496
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Author(s): Allen Loyd V Jr
Mar/Apr 2005
Pg. 167
PostScription: Experts Everywhere
Author(s): Rahe Hank
Jul/Aug 2004
Pg. 251-263
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards
Author(s): Newton David W, Trissel Lawrence A
Jul/Aug 2007
Pg. 302-305
Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Author(s): Okeke Claudia C
Sep/Oct 2007
Pg. 404-410
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels
Author(s): Allen Loyd V Jr, Okeke Claudia C
Mar/Apr 2021
Pg. 115-124
Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Author(s): Kelley Brian
Jul/Aug 2013
Pg. 283-288
United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013
Author(s): Newton David W
Jan/Feb 2023
Pg. 22-23
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone
Author(s): Brunner Scott
Jul/Aug 2016
Pg. 351
View Sample
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Author(s): Allen Loyd V Jr
Sep/Oct 2017
Pg. 356
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Author(s): Allen Loyd V Jr
May/Jun 2008
Pg. 216-229
Microbial Air-Sampling Equipment, Part 1: Meeting United States Pharmacopeia Chapter <797> Standards
Author(s): Kastango Eric S
Mar/Apr 2008
Pg. 136-144
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797>
Author(s): Allen Loyd V Jr, Okeke Claudia C
Jan/Feb 2003
Pg. 42-43
Technology Spotlight: Barrier Isolators
Author(s): Moussa Magdy, Rahe Hank, Lo Katharine
Mar/Apr 2005
Pg. 127-130
Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding--Sterile Preparations
Author(s): Newton David W
Jan/Feb 2012
Pg. 6-10
Misinterpretation of United States Pharmacopeia Chapter <797>
Author(s): McElhiney Linda F
Mar/Apr 2014
Pg. 94-99
A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards
Author(s): Marks Zach
Jul/Aug 2015
Pg. 303-305
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Author(s): Miller David G